Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | July 16, 2020 | July 28, 2020 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 02, 2023 | June 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,847 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 17,847 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
CASTLE BIOSCIENCES INC
Report date July 16, 2020 · Filed July 28, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy trust | 21,723 |
Last balance in matching sequence
After 2020-07-16 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-07-16 · Sale · Disposed 1,228 · Balance 23,495 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 2 · 2020-07-16 · Sale · Disposed 1,763 · Balance 21,732 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 3 · 2020-07-16 · Sale · Disposed 9 · Balance 21,723 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
VERACYTE, INC.
Report date June 02, 2023 · Filed June 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,377 |
Reported balance
After 2023-06-02 transaction · row 1
1 source rowRow 1 · 2023-06-02 · Tax withholding · Disposed 1,304 · Balance 41,377 F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectThe Bonnie H. Anderson Living Trust | 134,800 |
Reported balance
Holding disclosure · report date 2023-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 134,800 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2026 Filed Feb 18, 2026 21:15 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001588970-26-000002 · form4-02182026_040201.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,847 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:24 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 3,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-004616 · form4-02192025_090211.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,327 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2026. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:01 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000844 · form4-01092024_090134.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,029 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:48 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,304 | $26.72 | $34,842.88 |
DisclosureSEC source: 0001384101-23-000080 · wf-form4_168608449229750.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,377 F1 · kind: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-23-000048 · wf-form4_168185062639314.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,117 Underlying: Common Stock · 34,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 34,000 | $22.04 | $749,356.60 |
DisclosureSEC source: 0001384101-23-000048 · wf-form4_168185062639314.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,681 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $21.78 to $22.65. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 34,000 | $5.61 | $190,740.00 |
DisclosureSEC source: 0001384101-23-000048 · wf-form4_168185062639314.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:54 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-23-000040 · wf-form4_167900006769897.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,117 Underlying: Common Stock · 34,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:54 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 34,000 | $22.76 | $773,887.60 |
DisclosureSEC source: 0001384101-23-000040 · wf-form4_167900006769897.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,967 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $22.46 to $23.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:54 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 34,000 | $5.61 | $190,740.00 |
DisclosureSEC source: 0001384101-23-000040 · wf-form4_167900006769897.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 01:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 8,994 | $24.10 | $216,755.40 |
DisclosureSEC source: 0001384101-23-000028 · wf-form4_167789221596863.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,967 F1 · kind: The reporting person is reporting the withholding of 738, 812, 492, and 6,592 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 2,063, 1,250, and 17,667 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020, February 26, 2021, and March 3, 2022 respectively, and does not represent a sale by the reporting person. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,117 Underlying: Common Stock · 34,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 4,494 | $26.64 | $119,726.45 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,961 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.59 to $26.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 29,506 | $26.30 | $776,111.07 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,455 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.58 to $26.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 34,000 | $5.61 | $190,740.00 |
DisclosureSEC source: 0001384101-23-000004 · wf-form4_167407967323620.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 22:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 63,247 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001384101-23-000002 · wf-form4_167356241552627.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,753 Underlying: Common Stock · 63,247 shares Expires 2024-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 22:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 63,247 | $25.13 | $1,589,194.72 |
DisclosureSEC source: 0001384101-23-000002 · wf-form4_167356241552627.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,961 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 22:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 63,247 | $14.34 | $906,961.98 |
DisclosureSEC source: 0001384101-23-000002 · wf-form4_167356241552627.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:28 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000684 · form4-01092023_090157.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,652 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,042 | $29.14 | $59,503.88 |
DisclosureSEC source: 0001384101-22-000149 · wf-form4_167036442737005.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,961 F1 · kind: The reporting person is reporting the withholding of 738, 812, and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · derivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,117 Underlying: Common Stock · 30,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 50,000 shares Expires 2024-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 45,460 | $28.60 | $1,300,301.47 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,003 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.21 to $28.85. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 34,540 | $27.81 | $960,446.87 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,463 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.20 to $28.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 30,000 | $5.61 | $168,300.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 50,000 | $14.34 | $717,000.00 |
DisclosureSEC source: 0001384101-22-000147 · wf-form4_167027736668491.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 9,244 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,756 Underlying: Common Stock · 9,244 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,844 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,844 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 9,244 | $9.05 | $83,658.20 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,844 | $8.86 | $16,337.84 |
DisclosureSEC source: 0001384101-22-000134 · wf-form4_166604061306981.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,042 | $19.18 | $39,165.56 |
DisclosureSEC source: 0001384101-22-000128 · wf-form4_166258414781633.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,003 F1 · kind: The reporting person is reporting the withholding of 738, 812, and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 2,063 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 21:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,769 | $27.82 | $160,497.04 |
DisclosureSEC source: 0001384101-22-000114 · wf-form4_166007979365285.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 112,426 F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.730 to $27.935. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 21:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 39,231 | $27.24 | $1,068,577.90 |
DisclosureSEC source: 0001384101-22-000114 · wf-form4_166007979365285.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 118,195 F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.710 to $27.705. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 76,917 | $27.71 | $2,131,370.07 |
DisclosureSEC source: 0001384101-22-000114 · wf-form4_166007979365285.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 157,426 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.09 to $28.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,042 | $18.23 | $37,225.66 |
DisclosureSEC source: 0001384101-22-000078 · wf-form4_165454723637529.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,045 F1 · kind: The reporting person is reporting the withholding of 738, 812, and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 01, 2022 Filed May 3, 2022 21:43 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 736 | $20.47 | $15,065.92 |
DisclosureSEC source: 0001384101-22-000070 · wf-form4_165161419911255.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,952 F1 · kind: The reporting person is reporting the withholding of 736 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,870 Restricted Stock Units granted on May 11, 2020 and does not represent a sale by the reporting person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 21:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 32,195 | $0.00 Strike: $26.02 | $0.00 |
DisclosureSEC source: 0001384101-22-000044 · wf-form4_164668845403223.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,195 Underlying: Common Stock · 32,195 shares Expires 2032-03-03 F2 · derivative.exercise_date: The option becomes exercisable as to 33% of the shares on each of the one-year, two-year and three-year anniversaries following grant date, subject to continued service of the Reporting Person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 21:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 17,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000044 · wf-form4_164668845403223.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,688 F1 · kind: Restricted stock units awarded on March 3, 2022 vest in full on March 2, 2023 subject to continuing service of the Reporting Person. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 22:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 4,521 | $27.84 | $125,864.64 |
DisclosureSEC source: 0001384101-22-000042 · wf-form4_164643329059433.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,021 F1 · kind: The reporting person is reporting the withholding of 838, 838, 889, and 1,956 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 1,875, 2,063 and 5,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:03 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000284 · edgar.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,682 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. F2 · balance_after: Includes 1,539 shares held by Trust, for which the Reporting Person is the sole beneficiary. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:42 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 11,286 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-21-000182 · wf-form4_163917252474255.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 11,286 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:42 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 11,286 | $8.86 | $99,993.96 |
DisclosureSEC source: 0001384101-21-000182 · wf-form4_163917252474255.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 22:26 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,288 | $39.22 | $89,735.36 |
DisclosureSEC source: 0001384101-21-000178 · wf-form4_163882960714591.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,256 F1 · kind: The reporting person is reporting the withholding of 738, 738 and 812 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 1,875 and 2,062 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:18 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,600 | $50.18 | $130,477.62 |
DisclosureSEC source: 0001384101-21-000159 · wf-form4_163225552291274.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 217,478 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2021. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:37 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,900 | $50.03 | $95,049.59 |
DisclosureSEC source: 0001384101-21-000157 · wf-form4_163165186122017.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Indirect · The Bonnie H. Anderson Living Trust Disclosed balance after: 220,078 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2021. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.08. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,288 | $52.97 | $121,195.36 |
DisclosureSEC source: 0001384101-21-000148 · wf-form4_163104889655603.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,544 F1 · kind: The reporting person is reporting the withholding of 738, 738 and 812 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 1,875 and 2,063 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,288 | $36.07 | $82,528.16 |
DisclosureSEC source: 0001384101-21-000094 · wf-form4_162283995384640.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Executive Chairwoman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,725 F1 · kind: The reporting person is reporting the withholding of 738, 738 and 812 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 1,875 and 2,062 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:34 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 14,065 | $0.00 Strike: $5.61 | $0.00 |
DisclosureSEC source: 0001384101-21-000087 · wf-form4_162145643157642.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,117 Underlying: Common Stock · 14,065 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:34 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 14,065 | $5.61 | $78,904.65 |
DisclosureSEC source: 0001384101-21-000087 · wf-form4_162145643157642.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 22:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 6,320 | $62.15 | $392,788.00 |
DisclosureSEC source: 0001384101-21-000036 · wf-form4_161489538807035.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,948 F1 · kind: The reporting person is reporting the withholding of 988, 988 and 4,344 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875, 1,875 and 8,250 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.